Conditions: Rheumatoid Arthritis
Keywords: RA
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 624
Healthy volunteers: no

Brief summary:
The purpose of this new research study is to gain additional information about how safe and effective R935788 is over a longer period of time.

Detailed description:

Arms:
arm 1: R935788 50 mg tablet, orally, twice-a-day arm 2: R935788 100 mg tablet, orally, twice-a-day arm 3: R935788 100 mg tablet, orally, once-a-day arm 4: R935788 150 mg tablet, orally, once-a-day

Interventions: intervention 1: Fostamatinib Disodium (R935788)
Intervention descriptions: intervention 1: 50 mg PO BID; 100 mg PO BID; 100 mg PO QD; 150 mg tablet PO QD

Protocol document: